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Background: Arginine biosynthesis in Corynebacterium glutamicum consists of eight enzymatic steps, starting with
acetylation of glutamate, catalysed by N-acetylglutamate synthase (NAGS). There are different kinds of known
NAGSs, for example, “classical” ArgA, bifunctional ArgJ, ArgO, and S-NAGS. However, since C. glutamicum possesses
a monofunctional ArgJ, which catalyses only the fifth step of the arginine biosynthesis pathway, glutamate must be
acetylated by an as of yet unknown NAGS gene.
Results: Arginine biosynthesis was investigated by metabolome profiling using defined gene deletion mutants that
were expected to accumulate corresponding intracellular metabolites. HPLC-ESI-qTOF analyses gave detailed insights
into arginine metabolism by detecting six out of seven intermediates of arginine biosynthesis. Accumulation of
N-acetylglutamate in all mutants was a further confirmation of the unknown NAGS activity. To elucidate the identity of
this gene, a genomic library of C. glutamicum was created and used to complement an Escherichia coli ΔargA mutant.
The plasmid identified, which allowed functional complementation, contained part of gene cg3035, which contains an
acetyltransferase domain in its amino acid sequence. Deletion of cg3035 in the C. glutamicum genome led to a partial
auxotrophy for arginine. Heterologous overexpression of the entire cg3035 gene verified its ability to complement the
E. coli ΔargA mutant in vivo and homologous overexpression led to a significantly higher intracellular N-acetylglutamate
pool. Enzyme assays confirmed the N-acetylglutamate synthase activity of Cg3035 in vitro. However, the amino acid
sequence of Cg3035 revealed no similarities to members of known NAGS gene families.
Conclusions: The N-acetylglutamate synthase Cg3035 is able to catalyse the first step of arginine biosynthesis in
C. glutamicum. It represents a novel class of NAGS genes apparently present only in bacteria of the suborder
Corynebacterineae, comprising amongst others the genera Corynebacterium, Mycobacterium, and Nocardia. Therefore,
the name C-NAGS (Corynebacterineae-type NAGS) is proposed for this new family.
Keywords: Corynebacterium glutamicum, N-acetylglutamate synthase, NAGS, Arginine biosynthesis, ArgA,
HPLC-ESI-qTOFBackground
In prokaryotes, biosynthesis of arginine from glutamate
(Figure 1) is carried out by a series of eight enzymatic
reactions initiated by acetylation of glutamate, a reaction
catalysed by N-acetylglutamate synthase (NAGS). This
first step prevents glutamate from cyclisation and its fur-
ther use in proline biosynthesis [1]. After metabolisation
of N-acetylglutamate, biosynthesis proceeds via three* Correspondence: Joern.Kalinowski@Cebitec.Uni-Bielefeld.DE
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reproduction in any medium, provided the orenzymatic steps which form further acetylated inter-
mediates, until the acetyl group is removed in the
fifth step of this process. The resulting ornithine is
carbamoylated to citrulline. Addition of aspartate leads
to N-argininosuccinate, which is finally converted to
L-arginine [2].
Enzymes catalysing the formation of N-acetylglutamate
in prokaryotes exhibit a high degree of diversity. N-
acetylglutamate synthase activity was first discovered in
Escherichia coli [3]. Here, the two-domain protein ArgA
contains a carbamate kinase domain at its N-terminus
that is homologous to the next enzyme in arginined. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 General pathway of arginine biosynthesis in prokaryotes including two known routes for removal of the acetyl group. Vertical
arrows represent the linear pathway, whereas the alternative cyclic pathway in which the acetyl group is recycled by ornithine acetyltransferase
(encoded by argJ) is indicated by a dashed arrow. Intermediates and immediate precursors are given in bold letters, enzymes are in boxes. ArgJ*
designates bifunctional proteins. Abbreviations: HS-CoA = coenzyme A; Ac-CoA = acetyl-CoA; (P)Pi = (pyro)phosphate; HCO3- = bicarbonate.
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[4]. The N-acetylglutamate synthase domain, as well as
an acetyl-CoA binding region, is located at the C-
terminus of ArgA. This domain is related to the large
family of GCN5-related acetyltransferases (GNAT) [2].
ArgA from E. coli is strongly feedback-inhibited by L-ar-
ginine, leading to 50% inhibition at 0.02 mM [5]. Coen-
zyme A and N-acetylglutamate also inhibit the activity of
this enzyme: 2.5 mM CoA or 25 mMN-acetylglutamate
both result in 50% inhibition of ArgA [6]. In E. coli,
removal of the acetyl group is catalysed by ArgE
(N-acetylornithine deacetylase) during the fifth step
of arginine biosynthesis, which results in a linear
pathway [7].
For the acetylated intermediates, the majority of pro-
karyotes have a more efficient cyclic pathway in which
ArgJ (ornithine acetyltransferase, OAT) catalyses the
acetylation of glutamate [8]. ArgJ operates as a bifunc-
tional protein and uses both substrates, acetyl-CoA and
N-acetylornithine, thus, this enzyme exhibits both NAGS
and OAT activity [9]. In this case, NAGS activity isessential for priming arginine biosynthesis, but it has only an
anaplerotic function while most N-acetylglutamate is pro-
duced by ArgJ using L-glutamate and N-acetylornithine as
substrates. The acetyl group is recycled via transacetylation
of L-glutamate. Therefore the latter reaction is generally
preferred, explaining the low abundance of NAGS enzymes
in organisms exhibiting OAT [1].
Regulation of this metabolic pathway is generally
achieved through feedback inhibition of the second en-
zyme in the pathway, N-acetylglutamate kinase (ArgB)
by L-arginine [10] and/ or by feedback inhibition of ArgJ
by L-ornithine [8].
In most bacteria, either a bifunctional ArgJ or ArgA is
responsible for formation of N-acetylglutamate. How-
ever, there also exist some organisms such as Neisseria
gonorrhoeae [11] or Bacillus stearothermophilus [12]
exhibiting both a bifunctional OAT as well as a NAGS
gene. There are also OATs which are unable to use
acetyl-CoA as substrate and are, therefore, designated as
‘monofunctional’. An additional NAGS gene is needed in
this case, however, in organisms such as Streptomyces
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monofunctional ArgJ, no orthologue of ArgA can be
identified by sequence similarity searches [13]. In these
organisms, the glutamate acetylation mechanism re-
mains unclear, however, in 2005, Errey et al. discovered
a novel ArgA protein in Mycobacterium tuberculosis,
containing only a single domain and consisting of 174
amino acids [13]. This “short NAGS” version (S-NAGS)
is a putative GNAT-related enzyme and was later also
found in other genera including Thermus and Strepto-
myces. The proteins of this family possess only 150 to
180 amino acids, similar to the length of the C-terminal
acetyl-CoA domain of classical NAGS, however, are able
to complement E. coli argA mutants [14].
In addition to single-domain S-NAGSs, another group
of proteins exists in which a S-NAGS domain is fused
with an N-argininosuccinase (ArgH) domain, the protein
that catalyses the last step of the L-arginine biosynthesis
pathway. The argH(A) genes were found mainly in mar-
ine bacteria of the Alteromonas-Vibrio group [14,15]. It
is speculated that these S-NAGSs always require a com-
plex formation with a protein partner providing an effi-
cient glutamate binding site [2].
Corynebacterium glutamicum is a natural producer of
L-glutamate, a precursor of L-arginine and, accordingly,
its arginine biosynthesis has been the subject of intense re-
search. The earliest studies of this organism were
performed in 1958 by Udaka and Kinoshita, who analysed
the metabolic pathway of L-ornithine, an intermediate
of the arginine pathway. The authors recognised that
acetylated compounds form a cycle of reactions, in
which the acetyl group is recycled by generation of N-
acetylglutamate [16]. Hence, it was concluded that C.
glutamicum exhibits an OAT activity catalysed by ArgJ.
In 1996, Sakanyan et al. discovered the monofunctional
action of ArgJ by revealing its ability to complement E.
coli argE but not argA mutants. By performing enzyme
inhibition tests, they detected no influence on OATactivity
by L-arginine, however, a product inhibition was shown
when 5 mM L-ornithine was added to the ArgJ enzyme [8].
Nevertheless, ArgJ lacks NAGS activity and so investi-
gations to discover a glutamate acetylase responsible for
the first step in arginine biosynthesis were performed.
Recently, Hwang and Cho [17], who searched for C.
glutamicum N-acetyltransferase genes complementing
an auxotrophic ΔargJ mutant, claimed that Cg1722
(NCgl1469) demonstrates NAGS activity and that its
overexpression leads to an increase in ornithine produc-
tion. But shortly thereafter Kind et al. [18] revealed that
Cg1722 acetylates diaminopentane (cadavarine) instead
of glutamate, so that the NAGS gene of C. glutamicum
is still unknown.
In the work described here, we analysed arginine syn-
thesis in C. glutamicum by individually mutating singlegenes known to be involved in this synthesis pathway
and determining the patterns of accumulated metabolic
intermediates. In a complementation approach, we iden-
tified a C. glutamicum gene able to complement an
arginine-auxotrophic E. coli argA mutant. Enzyme activ-
ity tests as well as metabolic profiling demonstrated that
this gene is the functional analogue of ArgA in C.
glutamicum.
Results
Arginine biosynthesis of C. glutamicum was an integral
part of a number of previous studies which have eluci-
dated detailed knowledge of the genetic and enzymatic
organisation of this pathway [8], its regulation by the
transcriptional regulator ArgR, as well as the feedback
inhibition of ArgB by the end-product of the pathway,
L-arginine [19]. In order to complement the existing
understanding of this pathway, we chose to characterise
the metabolic intermediates of arginine metabolism
using defined individual knock-out mutants of all
known arginine biosynthesis genes located in the argin-
ine operon [8].
For this systematic metabolic study, auxotrophic mu-
tants for each arginine biosynthetic gene of the arg-
operon with an additional deletion of the transcriptional
regulator of arginine biosynthesis (e.g. ΔargRC, ΔargRJ)
were constructed. The knockout of the transcriptional
repressor ArgR led to transcriptional activation of the
ArgR regulon, consisting of the arg-operon, its sub-
operon argGH, and the carABpyrF-operon as demon-
strated by microarray hybridization analysis (Additional
file 1). To ensure equal conditions, C. glutamicum ATCC
13032 and all mutants were cultivated in minimal media
supplemented with L-arginine. By washing exponentially
grown cells and transferring them into unsupplemented
CGXII-medium, it is expected that auxotrophic strains
starve and growth is arrested while the direct substrate of
the removed enzyme should, therefore, accumulate, as has
been shown in previous studies [20,21]. For detection of
arginine biosynthesis intermediates, hydrophilic extracts
were analysed by HPLC-ESI-qTOF in positive ionisation
mode. Mean values for normalised peak areas of identified
[M+H]+ ions of N-acetylglutamate, N-acetylglutamate
semialdehyde, N-acetylornithine, ornithine, citrulline
and N-argininosuccinate are depicted in Figure 2.
N-acetylglutamyl phosphate was not detectable in any
sample examined, which could be due to insufficient ion-
isation of this compound in positive mode. Arginine was
as well not detected in any sample as was expected for
deletion mutants. For N-acetylglutamate semialdehyde, no
reference substance was available. Therefore, the re-
spective [M+H]+ ion (m/z = 174.0761) was fragmented by
applying automated MS/MS. The resulting spectrum
was compared to a theoretical fragmentation pattern. The
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Figure 2 Bar charts of normalised peak areas of six intermediates of arginine biosynthesis after HPLC-ESI-qTOF analysis. C. glutamicum
ATCC 13032 (WT) and seven double deletion mutants were cultivated with L-arginine until exponential phase. Then L-arginine was removed and
cells were further incubated to accumulate intracellular metabolites. The boxes in each diagram indicate the respective intracellular compound
and its mass-to-charge ratio. Peak detection and integration was performed on base peak chromatograms (BPC) of m/z-values of [M + H]+ ions.
Values that are significantly different from the wildtype level (Student’s T-test p < 0.05) are indicated by an asterisk. Error bars represent standard
deviations of four biological replicates.
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http://www.biomedcentral.com/1471-2164/14/713main fragment ion (m/z = 114.0550) can be explained by
consecutive neutral losses of one molecule H20 and one
acetyl group (C2H2O). After revision of full-scan MS data,
[M+H-H2O]
+ ion (m/z = 156.0655) and [M+H-H20-
C2H2O]
+ ion (m/z = 114.0517) could be observed in chro-
matograms of ΔargRD, that co-eluted with [M+H]+ ion
of N-acetylglutamate semialdehyde (Additional file 2).Comparison of metabolite profiles of different arginine
auxotrophic strains revealed that the intracellular inter-
mediates N-acetylglutamate semialdehyde, ornithine and
N-argininosuccinate were only accumulated in their cor-
responding mutant, namely in ΔargRD, ΔargRF, or
ΔargRH, respectively. However, citrulline was detected
in samples of strains ΔargRG, and ΔargRH. The latter
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to citrulline or, alternatively, a low conversion rate of
argininosuccinate synthetase. N-Acetylornithine was also
found in two of the mutants. A high pool size of this com-
pound was observed in ΔargRJ and a lower pool size in
ΔargRF, which again might imply a backlog. The accumu-
lation of N-acetylornithine in ΔargRJ provides clear
in vivo evidence for a NAGS activity in C. glutamicum,
catalysed by at least one other enzyme than ArgJ. Former
experiments performed by Sakanyan et al. in 1996
revealed that ArgJ of C. glutamicum only exhibited
monofunctional enzyme activity in vitro and in vivo [8].
N-Acetylglutamate was the only metabolite intermedi-
ate detectable in the wildtype and in all mutants. As in
the ΔargRJ mutant, the N-acetylglutamate pool was sig-
nificantly reduced in the ΔargRD strain, most probably
due to the lack of substrate for transacetylation by ArgJ.
However, the relatively high N-acetylglutamate pool in
the ΔargRC mutant is not directly explained by this.
Discovering a gene responsible for the first step of
arginine biosynthesis
For identification of a gene encoding the missing N-
acetylglutamate synthase in C. glutamicum ATCC 13032,
an E. coli JM109 ΔargA mutant was constructed by using
Red/ET recombination. After successful integration of the
gene deletion cassette, the selection marker was removed
by using FLP recombination. The constructed mutant was
tested on M9 minimal medium and no growth was ob-
served without L-arginine supplementation. Furthermore,
arginine auxotrophy of this mutant was not com-
plemented by ArgJ from C. glutamicum, as described in
literature [8].
To discover a gene able to complement the auxo-
trophic E. coli ΔargA mutant, a genomic library of C.
glutamicum ATCC 13032 was created. The procedure to
create a DNA library and its cloning in the shuttle
expression vector pZ8-2 are described in the Methods
section. E. coli ΔargA mutants were transformed with
the plasmid library. After 48 h of growth, a single colonydef1 cg3035
cg3035_d1 cg3035_d2
Δcg3035
2893594
Figure 3 Genomic map of the chromosomal region of C. glutamicum
ORFs as light grey arrows. The cloned region of the complementation plas
of primers (small open arrows) used to generate the deletion construct (ligwas obtained on minimal medium plates. The plasmid
was isolated from this clone and the DNA insert was se-
quenced. Analysis of the nucleotide sequence revealed a
1631 bp large DNA fragment of the C. glutamicum
ATCC 13032 genome [22] (Figure 3). The insert con-
tained the 3’ part of gene cg3035, encoding a putative N-
acetylglutamate synthase and the complete xthA gene
(cg3036) coding for exodeoxyribonuclease III. Since a
protein with N-acetylglutamate synthase activity (NAGS)
was searched for, Cg3035 with its GNAT-domain (glu-
tamate N-acetyltransferase domain) was the promising
candidate. Although the DNA fragment carried only
around 800 bp of the 1008 bp cg3035-gene, a Pfam data-
base search (UniProt entry Q8NM40_CORGL) disclosed
that the acetyltransferase domain of this protein is fully
encoded on the cloned DNA fragment.
The genomic organisation of cg3035 revealed an op-
eron structure together with cg3034 [23], coding for
def1, a putative peptide deformylase, since coding se-
quences of these two genes share an 11 bp long overlap.
Moreover, this implies a co-regulation of both proteins
by translational coupling. The gene product of cg3035 is
37.2 kDa in size and possesses an acetyltransf_1
(PF00583)-domain catalysing transfer of an acetyl group
to its substrate [24]. A coenzyme A binding pocket is lo-
cated upstream of the acetyltransferase domain. Never-
theless, an experimental validation of Cg3035 protein
function was necessary.
Validating the gene function of cg3035 by heterologous
complementation, gene deletion, metabolome analyses,
and enzyme assays
The complete open reading frame of cg3035 was ampli-
fied from C. glutamicum WT genome by PCR and
cloned into pZ8-1 together with a consensus ribosome-
binding site (RBS) of highly expressed genes [25]. ArgA
from E. coli was treated similarly to serve as positive
control. The resulting plasmids (pZ8-1::argA, pZ8-1::
cg3035) were transformed into E. coli ΔargA. As
expected, argA from E. coli allowed growth of arginine-cg3035_d3 cg3035_d4
xthA
Sequencing product
2894601
carrying cg3035. Cg3035 is indicated as dark grey arrow, adjacent
mid is shown as dark grey box. Also depicted are the binding positions
ht grey boxes). The deleted region is depicted as empty box.
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L-arginine supplementation. Growth on minimal medium
was also restored by cg3035, showing a functional
complementation.
To test whether cg3035 is involved in arginine biosyn-
thesis in C. glutamicum, growth of the deletion mutant
Δcg3035 was analysed on solid minimal medium without
L-arginine supplementation and compared to the C.
glutamicum wildtype (Additional file 3). After 48 h at
30°C the mutant Δcg3035 exhibits poor growth on
unsupplemented MM1 plates in comparison to the C.
glutamicum wildtype, indicating a bradytrophy of the
mutant due to arginine limitation. Therefore, Cg3035 is
required for full activity of arginine biosynthesis in C.
glutamicum, but not essential.
To characterise the function of Cg3035 in vivo, we
performed additional metabolic profiling experiments, in
which we compared samples of the deletion mutant
Δcg3035 and the overexpression strain WT pZ8-1::
cg3035 with regard to potential acetylation products
formed by Cg3035. Samples of C. glutamicum ATCC
13032 (WT) and C. glutamicum WT pZ8-1 served as
controls, respectively. Relative quantification of metabo-
lites revealed a strong decrease of the N-acetylglutamate
pool (fold change 0.31) in the deletion mutant Δcg3035
in comparison to the wildtype. In accordance to that,
overexpression of Cg3035 led to an almost tenfold (fold
change 9.69) increase of N-acetylglutamate (Figure 4),
providing clear evidence for the ability of Cg3035 to per-
form the first step in arginine biosynthesis. Interestingly,
N-acetylglutamine was the only other N-acetylated amino0.1
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Figure 4 Diagram of normalised peak areas of N-acetylglutamate
in different C. glutamicum strains. Hydrophilic metabolites were
extracted from C. glutamicum ATCC 13032 (WT), Δcg3035 as well as WT
pZ8-1 (empty vector) and WT pZ8-1::cg3035. Peak detection and
integration was performed on base peak chromatograms of m/z-
values of [M + H]+ ions. Error bars represent standard deviations of four
biological replicates. Values that are significantly different from the
wildtype level (Student’s T-test p < 0.01) are indicated by an asterisk.acid detectable. This metabolite was previously reported
to be produced by strains of the species C. glutamicum
(formerly “Brevibacterium lactofermentum”) [26]. The N-
acetylglutamine pools were almost identical in all four
strains tested (Additional file 4). In addition, relative quan-
tifications of L-citrulline (Additional file 5) and L-arginine
(Additional file 6) were performed. Here, the pool of both
metabolites significantly decreased in the Δcg3035 mutant
(fold change 0.16 and 0.50, respectively) and significantly
increased about twofold in WT pZ8-1::cg3035 (fold
change 2.10 and 2.28, respectively). For lysine, an amino
acid derived from aspartate, neither deletion nor over-
expression of cg3035 had an effect on the intracellular
concentration (Additional file 7). Here, it must be men-
tioned that cg3035 is not part of the ArgR regulon.
Since N-acetylglutamate synthases display a high de-
gree of specificity for acetyl-CoA and L-glutamate as
substrates [13], enzyme assays with crude protein ex-
tracts were performed to measure the specific NAGS ac-
tivity of Cg3035. To test for specificity of the NAGS
measurement, acetyl-CoA was added as single substrate
and no consumption of acetyl-CoA was found (data not
shown). Then, NAGS activities were determined in
crude extracts of either C. glutamicum ATCC 13032 or
the deletion mutant Δcg3035 carrying the empty over-
expression vectors pZ8-1 or pZ8-1::cg3035 (Table 1).
First, a residual NAGS activity in the absence of Cg3035
in the deletion mutant harbouring the empty vector was
determined to be 13.8 mU mg-1 protein. Second, the en-
dogenous NAGS activity specific for Cg3035 was calcu-
lated by subtracting the total NAGS activities of the
deletion mutant from that of the wildtype. This was
done for strains harbouring the empty vector and for
strains with the overexpressed Cg3035 separately. The
NAGS activities attributed to Cg3035 were similar at
11.5 mU mg-1 protein or 12.9 mU mg-1 protein, for vec-
tors pZ8-1 or pZ8-1::cg3035 respectively. Third, the add-
itional activity conferred by cg3035 overexpression was
193.7 mU mg-1 protein or 206.6 mU mg-1 protein, re-
spectively. This is a 16–17 fold increase in activity and
can be attributed to the multicopy effect as well as the
strong promoter of the expression vector.
In addition, NAGS activities of overexpressed ArgA of
E. coli and ArgJ of C. glutamicum were measured in the
wildtype background. As expected, ArgJ exhibited no
specific NAGS activity, explaining its inability to com-
plement the E. coli ΔargA mutant. ArgA from E. coli
was found to confer additional NAGS activity of ap-
proximately 18.6 mU mg-1 protein.
For a number of microorganisms, including E. coli
[27,28], Salmonella enterica serovar Typhimurium [29],
Pseudomonas aeruginosa [30], and Saccharomyces cerevisiae
[31], a strong feedback inhibition of NAGS activity by L-
arginine was found. Therefore, inhibition studies of
Table 1 Specific NAGS activities of C. glutamicum ATCC 13032 and C. glutamicum Δcg3035 carrying different plasmids
Straina Plasmid Specific NAGS activity
[mU mg-1 protein]
SD [mU mg-1 protein]b
C. glutamicum ATCC 13032 pZ8-1 25.31 0.27
C. glutamicum ATCC 13032 pZ8-1::argJ 24.59 1.24
C. glutamicum ATCC 13032 pZ8-1::argA 43.92 3.07
C. glutamicum ATCC 13032 pZ8-1::cg3035 231.91 9.91
C. glutamicum Δcg3035 pZ8-1 13.84 0.30
C. glutamicum Δcg3035 pZ8-1::cg3035 207.54 8.14
aPlasmid harboring cells were cultivated in CGXII medium with kanamycin. bValues are means of triplicate measurements.
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ornithine were performed. No changes in specific NAGS
activity of the crude extract of C. glutamicum ATCC
13032 pZ8-1::cg3035 were detected when up to 50 mM L-
ornithine or L-arginine was added to the reaction mixture
(data not shown).
Cg3035 establishes a novel class of NAGS genes
To determine how related Cg3035 is to other known
NAGS genes, comparisons between “classical” ArgA
proteins, bifunctional ArgJ, S-NAGS and ArgO from
Campylobacter jejuni [32] were performed by sequence
similarity-based searches with the Cg3035 protein se-
quence using the basic local alignment search tool
(BLAST) [33] at the NCBI. Cg3035 did not show signifi-
cant overall sequence similarities to members of other
classes. Sequence similarity is restricted to the acetyl-
transferase catalytic domain, being distantly related to
that of ArgA from E. coli (28% identity in 40 amino
acids), ArgJ from Bacillus subtilis (29% identity in 41
amino acids) and the S-NAGS form from M. tubercu-
losis (29% identity in 35 amino acids). No such similarity
was found to ArgO from C. jejuni. Since only the
GCN5-related N-acetyltransferase (GNAT) domain was
found to be conserved, and GNAT-domains can be
found in N-acetyltransferases belonging to many differ-
ent functional classes [34], it is apparent that Cg3035
represents a novel NAGS class.
To identify related sequences and structures of Cg3035,
BLASTP [33] with Cg3035 was used as query against the
RefSeq database to identify all similar proteins, resulting
in 486 hits including the query. The set of results was then
filtered retaining only those 383 proteins with at least 25%
sequence similarity over 80% of the length of Cg3035. For
reasons of clarity, all hits against non-actinobacteria (4)
and poorly defined species (72) were excluded. For
the same reason, for species with multiple sequenced
strains (for example, M. tuberculosis or Corynebacterium
diphtheriae) only one sequence was selected for further
analysis, preferably from the type strain, if available. The
remaining 138 sequences were aligned using COBALT
[35] and a Fast-Minimum-Evolution tree was built(Figure 5a). Based on this tree, it is apparent that there are
two distinct groups of possible orthologues: one containing
only sequences (88) from the suborder Corynebacterineae
(“Corynebacteriales”; classification according to latest
version of Bergey’s manual [36]) and one comprised
of representatives (50) from other suborders of the
Actinomycetales, mostly Streptomycineae (31).
Additional support for these two groups of orthologues
can be derived from an analysis of the genomic context:
in Corynebacterineae (including Corynebacterium spp.,
Mycobacterium spp., Nocardia spp., Rhodococcus ssp. and
Gordonia ssp.), possible cg3035 orthologues are strongly
associated with def2, encoding peptide deformylase, and
xthA, encoding exodeoxyribonuclease III (Figure 5b). In
contrast, the possible orthologue is often located adjacent
to a gene encoding a ferredoxin in the second group.
Therefore, only the sequences of the most likely ortho-
logues, the 87 from Corynebacterineae, were realigned
using COBALT and the location of the putative N-
acyltransferase domain (based on a Pfam-A hit) was
marked (Additional file 8).
Discussion
Metabolite profiling analyses provide new insight into
arginine biosynthesis
In the experiments described here, a systematic ap-
proach was performed using defined deletion mutants of
C. glutamicum that were expected to accumulate intra-
cellular metabolites. No stable isotope labelled internal
standards for correction of ion suppression effects were
used in these experiments, therefore, only a qualitative
analysis of changes in metabolite pools could be
performed. Six out of seven intermediates of arginine
biosynthesis were found with the applied HPLC-ESI-
qTOF method and the results provide new insights
concerning metabolism within the arginine pathway.
Interestingly, two metabolites accumulated in different
mutants – N-acetylornithine was found in the two mu-
tants ΔargRJ and ΔargRF, and citrulline accumulated in
ΔargRG and ΔargRH mutants. In both cases, there was
not only an accumulation in the mutant which was de-
fective in the subsequent metabolic reaction, however,
BKineococcus radiotolerans
0.1Streptosporangium roseum
Tsukamurella paurometabola
Gordonia (14)
Dietzia alimentaria
Corynebacterium (37)
Mycobacterium (23)
Nocardia (4)
Rhodococcus (8)
Janibacter hoylei
Demetria terragena
Kribbella flavida
Sporichthya polymorpha
Tetrasphaera elongata
Aeromicrobium marinum
Kineosphaera limosa
Streptomyces (31)
Catellatospora koreensis
Salinispora pacifica
Longispora albida
Stackebrandtia nassauensis
Microlunatus phosphovorus
Acidothermus cellulolyticus
Actinoalloteichus spitiensis
Actinosynnema mirum
Corynebacterineae
Other
Actinomycetales
A
Figure 5 Phylogenetic analysis of Cg3035 relatives in other organisms and genomic context of cg3035 in different bacteria. A) Cg3035
was used as query against the RefSeq database of BLASTP to identify similar proteins. The most likely orthologues of Cg3035 were aligned using
COBALT [35] and a Fast-Minimum-Evolution tree was built with this software. B) The freeware tool GeConT II (http://bioinfo.ibt.unam.mx/gecont/
index.cgi) was used to visualise the genomic context of cg3035 and its orthologous genes within fully sequenced bacterial genomes [37]. Species
names abbreviated as in http://www.expasy.ch/cgi-bin/speclist.
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next reaction. This could indicate a backlog from the ac-
cumulated metabolite to its precursor.N-acetylornithine was accumulated in ΔargRJ, which
confirmed its anticipated function as ornithine acetyl
transferase (OAT). The measurements of intracellular
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a strongly reduced pool in the ΔargRJ mutant. For or-
ganisms having such a cyclic arginine pathway, this de-
crease illustrates a preference for transacetylation by
ArgJ instead of using the less economic ArgA activity to
produce N-acetylglutamate [8].
Since no transacetylation should occur in mutants up-
stream of ArgJ the behavior of ΔargRD mutant is con-
sistent with a low intracellular N-acetylglutamate pool. It
is puzzling, however, that in the ΔargRC mutant the N-
acetylglutamate pool is similar to the ΔargRB mutant
and the wildtype. In ΔargRB the accumulation of N-
acetylglutamate can be explained by the interruption of
biosynthesis. The unexpected high N-acetylglutamate
pool in ΔargRC can either be interpreted by an equilib-
rium of the reaction catalysed by ArgB on the side of
N-acetylglutamate or by a possible instability of the
phosphorylated N-acetylglutamate and its breakdown to
N-acetylglutamate. In the wildtype, the feedback inhib-
ition of ArgB is the possible cause for accumulation of
N-acetylglutamate.
In vivo and in vitro experiments confirm the ability of
Cg3035 to acetylate L-glutamate
In this study, the function of Cg3035 to use acetyl-CoA
for acetylation of glutamate was demonstrated in vivo
and in vitro. Besides complementation of the auxotrophic
E. coli ΔargA mutant, overexpression of cg3035 led to a
higher amount of intracellular N-acetylglutamate, whereas
deletion of this gene resulted in a reduction of the intra-
cellular N-acetylglutamate pool. From in vitro enzyme as-
says using crude extracts it was shown that NAGS
enzyme activity also correlated well with the genotype re-
garding cg3035. L-glutamate most probably is the pre-
ferred amino acid substrate for Cg3035. Interestingly, the
S-NAGS variant in M. tuberculosis has a higher activity
with L-glutamine [13]. Indeed, N-acetylglutamine was
found in all C. glutamicum strains tested, but in levels un-
affected by the presence or absence of cg3035. Since no
other N-acetylated amino acids were found in our
metabolome analyses of C. glutamicum, this indicates that
an involvement of Cg3035 in N-acetylglutamine synthesis
is unlikely. On the other hand, the correspondence in
the pools of N-acetylglutamate to those of the amino
acids L-citrulline and L-arginine further strengthens the
functional assignment of Cg3035 as integral part of ar-
ginine biosynthesis.
Cg3035 – A novel form of N-acetylglutamate synthase
The protein encoded by cg3035 can be compared to
known NAGS enzyme classes. Four different kinds of
NAGS enzyme families were described until now [2],
however, Cg3035 fits into none of them. Different from
classical known N-acetylglutamate synthases found, forexample in E. coli, Cg3035 has only a single protein do-
main. With a length of 335 amino acids, it is shorter
than the classical ArgA, although it is larger than the
150–180 amino acids long S-NAGS found, for example,
in M. tuberculosis.
Homologues of the Cg3035 protein were found in
other Corynebacteria as well as in diverse members of
the suborder Corynebacterineae, such as in Rhodococcus
spp., Nocardia spp., or Mycobacterium spp. Analysis of
the genomic context revealed a conserved arrangement
of three genes encoding peptide deformylase, N-
acetylglutamate synthase, and exodeoxyribonuclease III
among the fully sequenced genomes of this bacterial
suborder. Although no functional relationship of these
genes is apparent, the conserved genomic context
strengthens the view that Cg3035 and its closely similar
sequences in the other species of the Corynebacterineae
represent true orthologues [37].
It is unclear what the evolutionary driving forces were
for the formation of the different NAGS protein families.
The dissimilarity of NAGS proteins was noted before
and attributed to an independent evolution or a more
rapid evolution leading to much higher divergence than
the sequences of other arginine biosynthesis proteins [1].
Since the growth behaviour experiment on minimal
medium revealed a bradytrophy of Δcg3035 compared to
the wildtype, this indicates that there is at least one
other enzyme which is able to perform acetylation of
glutamate in C. glutamicum ATCC 13032. Candidates
for this are proteins with acetyltransferase domains. Be-
sides Cg1722, eight other proteins with acetyltransferase
domains are found in C. glutamicum, however, these
have yet to be characterised.
It could be, however, that Cg3035 is not involved ex-
clusively in arginine biosynthesis. This is not only indi-
cated by the conserved arrangement of cg3035 with
genes involved in peptide or RNA processing. The lack
of transcriptional repression of cg3035 by ArgR and
feedback inhibition of Cg3035 by one of the products of
arginine biosynthesis, arginine or ornithine also suggests
such a role. The initial transacetylation step is a
common target to control arginine metabolism, indeed,
all previously known microbial NAGS enzymes are
feedback-inhibited by arginine. It is well possible that N-
acetylglutamate is a non-exclusive precursor of arginine
biosynthesis, however, is also involved in other biosyn-
thesis pathways. Although it is not known what these
biosynthetic pathways produce, the occurrence of N-
acetylglutamine [38] is an indication for hitherto
unknown pathways in Corynebacteria in which N-
acetylglutamate could play a role. Consequently, in C.
glutamicum, ArgB would then be the first enzyme of the
arginine specific pathway and is feedback-inhibited by
L-arginine [10].
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In this study, we investigated the metabolites of arginine
biosynthesis in targeted biosynthetic mutants of C.
glutamicum. Through these investigations, we have
found evidence for a missing enzyme which performs
the first step of this process, the acetylation of glutamate
catalysed by an N-acetylglutamate synthase.
By complementation of an auxotrophic E. coli ΔargA
mutant with genomic DNA of C. glutamicum, the gene
cg3035 was implicated as the enzyme responsible for this
acetylation. A deletion of this gene led to a partial argin-
ine auxotrophy and further experiments on genetic, en-
zymatic, and metabolomic levels demonstrated the
ability of its encoded protein to act as NAGS, using
acetyl-CoA for acetylation of glutamate. These findings
added significantly to the knowledge on arginine metab-
olism in C. glutamicum. The NAGS enzyme Cg3035 es-
tablishes a novel class of N-acetylglutamate synthases
with orthologues found exclusively in members of the
suborder Corynebacterineae. Therefore, we propose to
name this novel class of NAGS containing Cg3035 and
its apparent orthologues C-NAGS (Corynebacterineae-
type NAGS). This is simply a proposal, and it would be in-
teresting to analyse in future studies if these orthologousTable 2 Bacterial strains and plasmids
Name Relevant genotype/informationa
Strains
E. coli JM109 F´ traD36, proA+B+, lacIq Δ(lacZ,)M15/ Δ(lac-pro
endA1, thi, hsdR17
E. coli JM109 ΔargA JM109 with deleted argA gene
C. glutamicum ATCC 13032 Wild type (WT), Nxr
ΔargRC C. glutamicum ATCC 13032 with deleted argR
ΔargRJ C. glutamicum ATCC 13032 with deleted argR
ΔargRB C. glutamicum ATCC 13032 with deleted argR
ΔargRD C. glutamicum ATCC 13032 with deleted argR
ΔargFR C. glutamicum ATCC 13032 with deleted argR
ΔargRG C. glutamicum ATCC 13032 with deleted argR
ΔargRH C. glutamicum ATCC 13032 with deleted argR
Δcg3035 C. glutamicum ATCC 13032 with deleted cg30
Plasmids
pK18mobsacB sacB, lacZα, Kmr , mcs mobilizable vector, allo
in C. glutamicum
pZ8-1 E. coli-C. glutamicum shuttle expression vecto
pZ8-2 modified pZ8-1 where the multiple cloning s
BamHI-site and a consensus RBS was included
pZ8-1::argA pZ8-1 containing the argA structural gene fro
pZ8-1::cg3035 pZ8-1 containing the cg3035 structural gene
pZ8-1::argJ pZ8-1 containing the argJ structural gene fro
ar, Superscript indicates resistance; Nx, nalidixic acid; Km, kanamycin.candidates demonstrate functional catalysis of the same
reaction.
Methods
Bacterial strains, growth conditions, plasmids,
and oligonucleotides
The bacterial strains and overexpression plasmids used in
this study are listed in Table 2. Oligonucleotide primers
and plasmids for deletions are listed in Additional files 9
and 10. C. glutamicum strains were grown at 30°C in
CGXII minimal medium (pH 7) consisting of (per liter)
20 g (NH4)2SO4, 5 g urea, 1 g KH2PO4, 1 g K2HPO4,
0.25 g MgSO4 ∙ 7H2O, 10 mg FeSO4 ∙ 7H20, 10 mg
MnSO4 ∙ 7H20, 1 mg ZnSO4 ∙ 7H20, 0.2 mg CuSO4,
0.02 mg NiCl2 ∙ 6H20, 0.2 mg biotin, 0.42 mg thiamine,
0.03 mg protocatechuate and 40 g glucose [39]. The
arginine-auxotrophic strains used for metabolic analyses
were grown on CASO plates at 30°C for 36 h, inoculated
into 10 mL of CGXII medium in 100 mL shake flasks, and
incubated o/n at 30°C and 300 rpm. Depending on the
cultivated strains and experiments, CGXII media was
supplemented with 0.5 mM L-arginine. Main cultures, car-
ried out in 250 mL shake flasks with 20 mL CGXII
medium, were inoculated from these precultures to anReference/source
AB), glnV44,e14-, gyrA96, recA1, relA1, New EnglandBiolabs
This study
American type culture collection
and argC genes This study
and argJ genes This study
and argB genes This study
and argD genes This study
and argF genes [40]
and argG genes This study
and argH genes This study
35 gene This study
ws for selection of double crossover [41]
r, Ptac, Km
r [42]
ite was exchanged by a sole This study
m E. coli This study
from C. glutamicum ATCC 13032 This study
m C. glutamicum ATCC 13032 This study
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bated at 30°C and 300 rpm until mid-exponential growth
phase (OD600 = 5–12); then cells grown without L-arginine
were harvested and cells cultivated with supplement were
transferred into 50 mL tubes and centrifuged at RT for
5 min at 5,000 × g. For depletion of L-arginine, cultures
were washed with 20 mL prewarmed (30°C) and un-
supplemented CGXII medium. Immediately, cells were
resuspended in 20 mL prewarmed CGXII medium with-
out L-arginine, transferred back into sterile 250 mL shake
flasks and shaken for another 2 h at 30°C and 300 rpm.
For each strain, four biological replicates were prepared.
For the generation of 13C-labelled internal standard, C.
glutamicum pZ8-1::cg3035 was grown in shake flasks with
2% (w/v) [U13C]-glucose as sole carbon source.
E. coli strains carrying plasmids were routinely grown
on solid Antibiotic Medium No. 3 (PA) (Oxoid, Wesel,
Germany) at 37°C. Tests for arginine auxotrophy were
performed using M9 minimal medium plates [43]. When
needed, antibiotics were added at the following con-
centrations: 50 μg mL-1 kanamycin for E. coli and
25 μg mL-1 kanamycin and 50 μg mL-1 nalidixic acid for
C. glutamicum. Bacterial growth was monitored by
measuring the optical density at 600 nm (OD600).
DNA isolation, manipulation, and analysis
Chromosomal DNA of C. glutamicum and E. coli
MG1655 was isolated as described previously [44]. Iso-
lation of plasmid DNA from E. coli cells was done by
using a GeneJET Plasmid Miniprep Kit (Fermentas, St.
Leon-Rot, Germany). PCR amplification of DNA was
carried out with Phusion polymerase (Finnzymes,
Vantaa, Finland) in an Eppendorf Mastercycler pro S.
All PCR setups were done according to the manufac-
turers´ protocols. Modification of DNA, analysis by agar-
ose gel electrophoresis and ligation were performed using
standard procedures [43]. All oligonucleotides used in this
study (Additional file 9) were obtained from Metabion
(Martinsried, Germany). PCR products were purified with
a NucleoSpin Gel and PCR Clean-up Kit (Macherey-
Nagel, Düren, Germany). Transformation of E. coli with
plasmid DNA was performed using the rubidium chloride
method [45], C. glutamicum cells were transformed by
electroporation [46].
Construction of defined chromosomal deletions
Plasmids for defined chromosomal deletions in C.
glutamicum ATCC 13032 from start to stop codon were
constructed using the geneSOEing method described by
Horton et al. [47]. In each deletion, the complete cod-
ing regions were removed exactly. One exception was
the deletion of argB, since it contains the ribosome-
binding site (RBS) for the argD coding sequence located
downstream. In this case, the deletion of argB wascarried out in a way that its RBS was fused to the argD
coding region in a proper distance. The resulting fusion
products were digested with restriction enzymes corre-
sponding to the cleavage sites introduced via PCR (Add-
itional file 9) and ligated into an appropriately digested
pK18mobsacB [41]. The final non-replicable plasmids
were transformed into C. glutamicum ATCC 13032 and
integration into the chromosome by single-crossover
was selected on CASO (Carl Roth, Karlsruhe, Germany)
plates supplemented with 25 μg mL-1 kanamycin. A sec-
ond recombination to enable plasmid excision was
performed by spreading the transformants on CASO
plates containing 10% (w/v) sucrose. Colonies from
these plates were tested for the desired kanamycin-
sensitive and sucrose-resistant phenotype by parallel
picking. PCR experiments were used to verify deletions
in the C. glutamicum chromosome.
For construction of E. coli JM109 ΔargA the Quick &
Easy E. coli Gene Deletion Kit (Gene Bridges, Heidelberg,
Germany) was used. Red/ET cloning and removal of the
selection marker was performed according to the manu-
facturer’s instructions.
Construction of expression vectors
To generate overexpression constructs of genes coding
for a putative N-acetylglutamate synthase, genes of inter-
est were amplified via PCR using C. glutamicum ATCC
13032 or E. coli MG1655 genomic DNA, respectively.
The PCR primers used are listed in Additional file 9.
The resulting PCR products were cleaved using restric-
tion sites added by the PCR primers and ligated into
plasmid pZ8-1, digested with the corresponding enzymes.
After transformation of E. coli JM109, the obtained plas-
mids were isolated and their inserts sequenced. The final
plasmids were then transformed into E. coli JM109 ΔargA
and C. glutamicum strains.
To ensure translation of inserted ORFs in E. coli, the
multiple cloning site of the shuttle expression vector
pZ8-1 was exchanged by a sole BamHI-site. Addition-
ally, a consensus ribosomal binding site (RBS) of highly
expressed genes (identical to the complement of mRNA-
binding site of the 16S rRNA [25]) was cloned upstream
this restriction site. The resulting vector was named
pZ8-2.
Generation of a genomic library from C. glutamicum ATCC
13032 and complementation of E. coli JM109 ΔargA
Isolation of genomic DNA was performed as described
elsewhere [44]. Five micrograms of DNA were partially
fragmented by the restriction enzyme Bsp143I (Sau3AI)
for 4 minutes. Since this step generated sticky ends com-
plementary to the BamHI-site, cloning in a vector was
enabled. The size distribution of genomic DNA frag-
ments was analysed on a DNA High Sensitivity chip by
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Santa Clara, Canada). The total DNA concentration was
41.75 ng μL-1, comprising fragments in the range of
700–9000 bp with an average DNA fragment size of
4.2 kb. Genomic DNA fragments were cloned into the
constitutively expressing pZ8-2 vector harboring a Ptac-
promoter. Partially digested genome and linear pZ8-2
vector were ligated and transformed into E. coli JM109
ΔargA mutant. Before plating on M9 minimal medium
plates with kanamycin, the transformed cells were
washed with 1x TE buffer to remove remaining compo-
nents of the regeneration medium, for example amino
acids. M9 minimal medium plates were incubated for
48 h at 37°C.Cell harvesting, metabolite extraction, and sample
preparation
Cell harvesting and metabolite extraction were performed
as previously [48,49]. Two milliliters of bacterial culture
were transferred into a 2 mL reaction tube with screw cap
and centrifuged at 20,000 × g for 15 s. The supernatant
was discarded and the cell pellet was immediately frozen
in liquid nitrogen. Frozen cell pellets were freeze-dried
within 16 h, using a Christ RVC 2-18 rotational-vacuum-
concentrator in combination with a Christ CT 02-50
cooling trap (Martin Christ, Osterode, Germany) and a
RZ 2.5 rotary vane pump (Vacuubrand, Wertheim,
Germany). A total of 950 mg of silica beads (0.5 mm dia.)
and 1 mL of aqueous methanol 80% (v/v) containing
20 μM 2-aminobenzimidazole were added, cells were then
disrupted by shaking 3 times in a Precellys 24 (PEQLAB
Biotechnologie, Erlangen, Germany) mill at 6,000 rpm
with 1 min cycles and 5 s breaks. Cell debris was separated
by centrifugation at 20,000 × g at RT for 20 min. Seven
hundred microliters of the hydrophilic extracts were
transferred into 1.5 mL glass vials and evaporated to
complete dryness under a nitrogen stream using a
Reacti-Therm III heating/stirring module equipped with
a Reacti-Vap III nitrogen evaporator (Pierce, Rockford,
IL, USA).Sample preparation for qualitative LC-MS analysis
Samples were dissolved in 200 μL of water and mixed
by vortexing for 10 s. In order to remove remaining
particles, samples were transferred into 1.5 mL reac-
tion tubes and centrifuged at 20,000 rpm at 4°C for
20 min. Supernatants were transferred into new
1.5 mL reaction tubes and stored at -80°C. Prior to
analysis, a 10 μL aliquot of each sample was trans-
ferred into a 1.5 mL glass vial with inlet (5 mm dia.).
Subsequently, 0.1 μL formic acid and 90 μL aceto-
nitrile were added. Samples were mixed by vortexing
for 5 s and placed into the autosampler.Sample preparation for quantitative LC-MS analysis
Samples were dissolved in 50 μL of water and mixed by
vortexing for 10 s. Samples were transferred into 1.5 mL
reaction tubes and centrifuged at 20,000 rpm at 4°C for
20 min to remove remaining particles. Supernatants
were transferred into new 1.5 mL reaction tubes and
stored at -80°C. Prior to analysis, a 15 μL aliquot of each
sample was transferred into a 1.5 mL glass vial with inlet
(5 mm dia.) and 5 μL of 13C-labelled internal standard
was added. Samples were mixed by vortexing for 5 s and
placed into the autosampler.
HPLC-ESI-QTOF conditions
LC-MS data were obtained using a LaChromUltra (Hitachi
Europe, UK) HPLC system coupled to a microTOF-Q
hybrid quadrupole/time-of-flight mass spectrometer
(Bruker Daltonics, Bremen, Germany), equipped with an
electrospray ionisation (ESI) source. Separation of metab-
olites was performed on a Cogent diamond hydride col-
umn (MicroSolv Technologies; 150 × 2.1 mm; 3 μm
particles) operated in aqueous normal phase mode. Eluent
A: 50% acetonitrile (v/v), 50% water (v/v) + 0.1% (v/v) for-
mic acid and B: 90% acetonitrile (v/v), 10% water (v/v) +
0.1% (v/v) formic acid were prepared freshly and stored in
PTFE bottles. Flow rate was set to 400 μL min-1 and gradi-
ent elution was performed as follows: t = 0 min, 100% B;
t = 6 min 0% B; t = 7 min, 0% B; t = 8.5 min 100% B; t =
13 min 100% B. MS detection was performed with ESI
source operated in positive ionisation mode (Additional file
11). Nitrogen was used as sheath, dry, and collision gas. So-
dium formate solution (0.1 M) in 50% (v/v) isopropanol
was used for external mass calibration and was injected
into the ESI source at the beginning of each analysis, using
a switch valve and a segmented acquisition method. For
targeted detection of N-acetylglutamate, multiple reaction
monitoring (MRM) was applied. An additional segment
was introduced (Additional file 12), during which the
pseudomolecular ion was isolated and fragmented to gen-
erate characteristic product ions.
Processing of LC-MS(/MS) Data
Raw data were analysed using the Compass software
environment (Bruker Daltonics, Bremen, Germany).
Automatic internal mass calibration using an HPC qua-
dratic algorithm and identification of compounds was
achieved using Compass DataAnalysis (version 4.0 SP1).
The following steps were performed using Compass
QuantAnalysis (version 2.0 SP1). This included targeted
generation of base peak chromatograms (BPCs) for
expected m/z-values of [M+H]+ ions (Additional file 13),
peak detection, peak integration, and normalisation to the
peak areas of the internal standard. Normalisation of
resulting peak areas to cell dry weight (CDW) of samples,
calculation of mean values, calculation of standard
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cation were performed in a spreadsheet. To test signifi-
cance of differences in normalised peak areas between
different strains, a two-tailed Student’s T-test was applied.
Theoretical fragmentation patterns and mechanisms of
selected metabolites were generated on the basis of
chemical structure files using Mass Frontier 4.0 Spectral
Interpretation Software (HighChem, Bratislava, Slovakia).
Preparation of crude protein extracts of bacterial cultures
C. glutamicum protein extracts were prepared from cells
grown to mid-exponential growth phase in liquid CGXII
medium. Twenty-five milliliters of bacterial culture was
harvested by 10 min of centrifugation at 4°C and
4,500 × g. Cell pellets were washed in 25 mL of 100 mM
Tris-HCl (pH 7.5) which was supplemented with 20 μM
PMSF. After removal of the supernatant, cells were
resuspended in 5 mL of 100 mM Tris-HCl (pH 7.5)
containing 20 μM PMSF. Cell suspension was split to
four 2 mL reaction tubes containing silica beads. Cell
disruption using the Precellys 24 bead mill was carried
out at a speed ratio of 6.5 for three time intervals of
30 s. Cell debris was removed by 20 min of centrifugation
at 4°C and 14,000 rpm. Protein concentrations of the
crude extracts were determined by using Roti-Nanoquant
(Roth, Karlsruhe, Germany), a modified Bradford assay,
according to instructions of the manufacturer.
Measurement of NAGS enzyme activity
NAGS activity of cell extracts was determined spectro-
photometrically with an LKB Biochrom 4060 photom-
eter (Amersham Pharmacia Biotech, Buckinghamshire,
England). Increase in absorbance at 412 nm due to for-
mation of 5-thio-2-nitrobenzoate was measured during
the reactions (see equation 1 & 2) between the free sulf-
hydryl group of CoA-SH, generated by the amino acid
acetylating activity, and 5,5-dithio-bis(2-nitrobenzoic
acid) (DTNB) [13].
Acetyl−CoAþ Glutamate→enzyme
CoA−SH þ N−Acetylglutamate
ð1Þ
CoA−SH þ DTNB→TNBþ CoA−derivative ð2Þ
Reaction was maintained at 25°C and continuously
monitored spectrophotometrically in a total volume of
500 μL. Assay mixtures contained 500 mM L-glutamate,
0.2 mM acetyl-CoA and 0.2 mM DTNB. All these sub-
stances were dissolved in 100 mM Tris-HCl (pH 7.5).
Reactions were initiated by addition of 10 μL of protein
extract. One unit of enzymatic activity is the amount of
enzyme catalysing the formation of 1 μmol of N-
acetylglutamate min-1 and specific NAGS activity wascalculated as the activity of enzyme per milligram of
total protein.
Additional files
Additional file 1: Genes with enhanced or reduced transcription in
C. glutamicum ΔargR compared with C. glutamicum ATCC 13032
(reference). A DNA microarray was performed to compare the
transcriptomes of C. glutamicum ΔargR and C. glutamicum ATCC 13032.
Total RNA was isolated from two biological replicates grown in minimal
CGXII medium to the exponential phase and used for hybridization of
two biological and two technical replicates, including a dye-swap.
Hybridisation and analysis of the microarray data was carried out as
described previously [50,51]. In the table all relevant genes are indicated
by their names or locus tags according to the C. glutamicum ATCC 13032
genome sequence ([22], GenBank NC_006958).
Additional file 2: Possible ionisation and fragmentation of N-
acetylglutamate semialdehyde after applying automated MS/MS.
Theoretical fragmentation pattern resulted in the following ions: [M + H]+
(m/z = 174.0761), [M + H-H20]
+ (m/z = 156.0655) and [M + H-H20-C2H2O]
+
(m/z = 114.0550), calculated with the software package HighChem Mass
Frontier 4.0 (HighChem, Ltd.; Bratislava, Slovakia).
Additional file 3: Growth test with C. glutamicum on MM1 minimal
medium. Tenfold serial cell dilutions were prepared and spotted on
MM1 minimal medium plates. C. glutamicum ATCC 13032 (Cg WT) was
used as positive control to compare the growth behavior of Cg Δcg3035.
Additional file 4: Relative concentrations of N-acetylglutamine in
different C. glutamicum strains. Hydrophilic metabolites were extracted
from C. glutamicum ATCC 13032 (WT), Δcg3035 as well as WT pZ8-1
(empty vector) and WT pZ8-1::cg3035. Peak detection and integration was
performed on base peak chromatograms of m/z-values of [M + H]+ ions.
Error bars represent standard deviations of four biological replicates. An
asterisk denotes p-values below 0.01.
Additional file 5: Relative concentrations of L-citrulline in different
C. glutamicum strains. Hydrophilic metabolites were extracted from C.
glutamicum ATCC 13032 (WT), Δcg3035 as well as WT pZ8-1 (empty
vector) and WT pZ8-1::cg3035. Peak detection and integration was
performed on base peak chromatograms of m/z-values of [M + H]+ ions.
Error bars represent standard deviations of four biological replicates. An
asterisk denotes p-values below 0.01.
Additional file 6: Relative concentrations of L-arginine in different
C. glutamicum strains. Hydrophilic metabolites were extracted from C.
glutamicum ATCC 13032 (WT), Δcg3035 as well as WT pZ8-1 (empty
vector) and WT pZ8-1::cg3035. Peak detection and integration was
performed on base peak chromatograms of m/z-values of [M + H]+ ions.
Error bars represent standard deviations of four biological replicates. An
asterisk denotes p-values below 0.01 and double asterisks mark p-values
below 0.05.
Additional file 7: Relative concentrations of L-lysine in different C.
glutamicum strains. Hydrophilic metabolites were extracted from C.
glutamicum ATCC 13032 (WT), Δcg3035 as well as WT pZ8-1 (empty
vector) and WT pZ8-1::cg3035. Peak detection and integration was
performed on base peak chromatograms of m/z-values of [M + H]+ ions.
Error bars represent standard deviations of four biological replicates. An
asterisk denotes p-values below 0.01.
Additional file 8: Multiple alignment of Cg3035 with its putative
orthologues from Corynebacterineae species. A BLASTP search with
Cg3035 as query was used against the RefSeq database to identify similar
proteins. Only proteins of actinobacteria with at least 25% sequence
similarity over 80% length of Cg3035 were used for an alignment using
the COBALT [35] software.
Additional file 9: Oligonucleotides used as primers to construct
defined C. glutamicum deletion mutants and expression plasmids.
Additional file 10: Plasmids used for targeted deletions.
Additional file 11: Parameters for microTOF control in full scan MS
mode.
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